Skip to main content
Top
Published in: Pediatric Drugs 3/2007

01-05-2007 | Current Opinion

Delays in Immunization Have Potentially Serious Health Consequences

Author: Prof. Fernando A. Guerra

Published in: Pediatric Drugs | Issue 3/2007

Login to get access

Abstract

When children are not administered vaccinations according to the recommended schedule, they not only fail to receive timely protection from preventable diseases at a time when they are most vulnerable, but also increase their risk of never fully completing the vaccination course. Both outcomes compromise a successful childhood immunization program. Although current data suggest that vaccination rates are near 95% for school-aged children in the US, the rate of timely vaccination is much lower. A number of large studies have found that the majority of children are not currently vaccinated on schedule. Moreover, immunization levels for 2- to 3-year-old children have reached a plateau.
It is essential to recognize that low overall rates of the targeted diseases mask the persistent threat they pose if adherence to vaccination schedules declines. A delay in one vaccine will produce a domino effect if catch-up adjustments in scheduled visits are not implemented aggressively. Published reports have demonstrated that failure to adhere to scheduled booster immunizations, not just the initial inoculation, results in resurgence of disease. Children fall off the vaccination schedule for a variety of reasons. Although many studies suggest that inadequate availability to healthcare is not a major determinant of delayed immunization, it still factors into parental decisions. Parents should be reminded of available healthcare options. From the clinician’s end, computerization of healthcare records should allow for the generation of reminders. It is vital for clinicians to be aware that there are few contraindications to vaccination. They should also be prepared to address parental concerns regarding the safety of vaccines and should not hesitate to use topical analgesics or distraction techniques to facilitate inoculation.
With the anticipation of several novel vaccines being added to the childhood and adolescent immunization schedule in the future, pediatricians face new challenges to not only provide every vaccination, but to do so in a timely manner. A lack of willingness on the part of the parent, or, occasionally, on the part of the clinician, to have multiple vaccines administered to the child during a single visit has been shown to be a significant cause of delayed vaccination. Since combination vaccines reduce the number of shots that need to be administered, the use of combination vaccines may provide the best opportunity to simplify the immunization schedule, increasing adherence in the process. Improved adherence to established schedules may present a major opportunity to further protect children from disease.
Literature
2.
go back to reference CDC. Vaccination coverage among children entering 2003–04 school year in the United States. MMWR Morb Mortal Wkly Rep 2004; 53: 1041–4 CDC. Vaccination coverage among children entering 2003–04 school year in the United States. MMWR Morb Mortal Wkly Rep 2004; 53: 1041–4
4.
go back to reference Gerberding J. Rubella no longer a major health threat. National Immunization Conference; 2005 Mar 21; Washington, DC Gerberding J. Rubella no longer a major health threat. National Immunization Conference; 2005 Mar 21; Washington, DC
5.
go back to reference CDC. Notifiable diseases/deaths in selected cities weekly information. MMWR Morb Mortal Wkly Rep 2006; 55: 1396 CDC. Notifiable diseases/deaths in selected cities weekly information. MMWR Morb Mortal Wkly Rep 2006; 55: 1396
6.
go back to reference Mell LK, Ogren DS, Davis RL, et al. Compliance with national immunization guidelines for children younger than 2 years, 1996–1999. Pediatrics 2005; 115: 461–7PubMedCrossRef Mell LK, Ogren DS, Davis RL, et al. Compliance with national immunization guidelines for children younger than 2 years, 1996–1999. Pediatrics 2005; 115: 461–7PubMedCrossRef
7.
go back to reference Barker L, Luman E, Zhao Z, et al. National, state, and urban area vaccination coverage levels among children aged 19–35 months: United States, 2001. MMWR Morb Mortal Wkly Rep 2002; 51: 664–6PubMed Barker L, Luman E, Zhao Z, et al. National, state, and urban area vaccination coverage levels among children aged 19–35 months: United States, 2001. MMWR Morb Mortal Wkly Rep 2002; 51: 664–6PubMed
8.
go back to reference Luman ET, Barker LE, McCauley MM, et al. Timeliness of childhood immunizations: a state-specific analysis. Am J Public Health 2005; 95: 1367–74PubMedCrossRef Luman ET, Barker LE, McCauley MM, et al. Timeliness of childhood immunizations: a state-specific analysis. Am J Public Health 2005; 95: 1367–74PubMedCrossRef
9.
go back to reference Kenyon TS, Izurieta H, Shulman ST, et al. Large outbreak of pertussis among young children in Chicago, 1993: investigation of potential contributing factors and estimation of vaccine effectiveness. Pediatr Infect Dis J 1996; 15: 655–61PubMedCrossRef Kenyon TS, Izurieta H, Shulman ST, et al. Large outbreak of pertussis among young children in Chicago, 1993: investigation of potential contributing factors and estimation of vaccine effectiveness. Pediatr Infect Dis J 1996; 15: 655–61PubMedCrossRef
10.
go back to reference Farizo KM, Cochi SL, Zell ER, et al. Epidemiological features of pertussis in the United States, 1980–1989. Clin Infect Dis 1992; 14: 708–19PubMedCrossRef Farizo KM, Cochi SL, Zell ER, et al. Epidemiological features of pertussis in the United States, 1980–1989. Clin Infect Dis 1992; 14: 708–19PubMedCrossRef
11.
go back to reference National Vaccine Advisory Committee. The measles epidemic: the problems, barriers, and recommendations. JAMA 1991; 266: 1547–52CrossRef National Vaccine Advisory Committee. The measles epidemic: the problems, barriers, and recommendations. JAMA 1991; 266: 1547–52CrossRef
12.
go back to reference Scheifele D, Halperin S, Law B, et al. Invasive Haemophilus influenzae type b infections in vaccinated and unvaccinated children in Canada, 2001–2003. CMAJ 2005; 172: 53–6PubMedCrossRef Scheifele D, Halperin S, Law B, et al. Invasive Haemophilus influenzae type b infections in vaccinated and unvaccinated children in Canada, 2001–2003. CMAJ 2005; 172: 53–6PubMedCrossRef
13.
go back to reference Wood D, Halfon N, Pereyra M, et al. Knowledge of the childhood immunization schedule and of contraindications to vaccinate by private and public providers in Los Angeles. Pediatr Infect Dis J 1996; 15: 140–5PubMedCrossRef Wood D, Halfon N, Pereyra M, et al. Knowledge of the childhood immunization schedule and of contraindications to vaccinate by private and public providers in Los Angeles. Pediatr Infect Dis J 1996; 15: 140–5PubMedCrossRef
14.
go back to reference Bolton P, Hussain A, Hadpawat A, et al. Deficiencies in current childhood immunization indicators. Public Health Reports 1998; 113: 527–32PubMed Bolton P, Hussain A, Hadpawat A, et al. Deficiencies in current childhood immunization indicators. Public Health Reports 1998; 113: 527–32PubMed
15.
go back to reference Dominguez SR, Parrott JS, Lauderdale DS, et al. On-time immunization rates among children who enter Chicago public schools. Pediatrics 2004; 114: 741–7CrossRef Dominguez SR, Parrott JS, Lauderdale DS, et al. On-time immunization rates among children who enter Chicago public schools. Pediatrics 2004; 114: 741–7CrossRef
16.
go back to reference Santoli JM, Huet NJ, Smith PJ, et al. Insurance status and vaccination coverage among US preschool children. Pediatrics 2004; 113: 1959–64PubMed Santoli JM, Huet NJ, Smith PJ, et al. Insurance status and vaccination coverage among US preschool children. Pediatrics 2004; 113: 1959–64PubMed
17.
go back to reference Luman ET, Barker LE, Shaw KM, et al. Timeliness of childhood vaccinations in the United States. JAMA 2005; 283: 1204–11CrossRef Luman ET, Barker LE, Shaw KM, et al. Timeliness of childhood vaccinations in the United States. JAMA 2005; 283: 1204–11CrossRef
18.
go back to reference CDC. National, state, and urban area vaccination coverage levels among children aged 19–35 months: United States, 2000. MMWR Morb Mortal Wkly Rep 2001; 50: 637–41 CDC. National, state, and urban area vaccination coverage levels among children aged 19–35 months: United States, 2000. MMWR Morb Mortal Wkly Rep 2001; 50: 637–41
19.
go back to reference Dombkowski KJ, Lantz PM, Freed GL. The need for surveillance of delay in age-appropriate immunization. Am J Prev Med 2002; 23: 36–42PubMedCrossRef Dombkowski KJ, Lantz PM, Freed GL. The need for surveillance of delay in age-appropriate immunization. Am J Prev Med 2002; 23: 36–42PubMedCrossRef
20.
go back to reference Grant CC, Roberts M, Scragg R, et al. Delayed immunisation and risk of pertussis in infants: unmatched case-control study. BMJ 2003; 326: 852–3PubMedCrossRef Grant CC, Roberts M, Scragg R, et al. Delayed immunisation and risk of pertussis in infants: unmatched case-control study. BMJ 2003; 326: 852–3PubMedCrossRef
21.
go back to reference Izurieta HS, Kenyon TA, Strebel PM, et al. Risk factors for pertussis in young infants during an outbreak in Chicago in 1993. Clin Infect Dis 1996; 22: 503–7PubMedCrossRef Izurieta HS, Kenyon TA, Strebel PM, et al. Risk factors for pertussis in young infants during an outbreak in Chicago in 1993. Clin Infect Dis 1996; 22: 503–7PubMedCrossRef
22.
go back to reference Wood DL, Brunell PA. Measles control in the United States: problems of the past and challenges for the future. Clin Microbiol Rev 1995; 8: 260–7PubMed Wood DL, Brunell PA. Measles control in the United States: problems of the past and challenges for the future. Clin Microbiol Rev 1995; 8: 260–7PubMed
23.
go back to reference CDC. Preventable measles among U.S. residents, 2001–2004. MMWR 2005; 54: 817–20 CDC. Preventable measles among U.S. residents, 2001–2004. MMWR 2005; 54: 817–20
24.
go back to reference Salmon DA, Haber M, Gangarosa EJ, et al. Health consequences of religious and philosophical exemptions from immunization laws. JAMA 1999; 282: 47–53PubMedCrossRef Salmon DA, Haber M, Gangarosa EJ, et al. Health consequences of religious and philosophical exemptions from immunization laws. JAMA 1999; 282: 47–53PubMedCrossRef
25.
go back to reference Marshall GS, Happe LE. Impact of first-year DTaP doses on the timeliness of the fourth dose of DTaP among children in a state Medicaid population [poster no. 269]. 40th National Immunization Conference; 2006 Mar 6–9; Atlanta (GA) Marshall GS, Happe LE. Impact of first-year DTaP doses on the timeliness of the fourth dose of DTaP among children in a state Medicaid population [poster no. 269]. 40th National Immunization Conference; 2006 Mar 6–9; Atlanta (GA)
26.
go back to reference Irigoyen M, Findley SE, Chen S, et al. Early continuity of care and immunization coverage. Ambul Pediatr 2004; 4: 199–203PubMedCrossRef Irigoyen M, Findley SE, Chen S, et al. Early continuity of care and immunization coverage. Ambul Pediatr 2004; 4: 199–203PubMedCrossRef
27.
go back to reference Heath PT, McVernon J. The UK Hib vaccine experience. Arch Dis Child 2002; 86: 393–9CrossRef Heath PT, McVernon J. The UK Hib vaccine experience. Arch Dis Child 2002; 86: 393–9CrossRef
28.
go back to reference Lieu TA, Black SB, Sorel ME, et al. Would better adherence to guidelines improve childhood immunization rates? Pediatrics 1996; 98: 1062–8PubMed Lieu TA, Black SB, Sorel ME, et al. Would better adherence to guidelines improve childhood immunization rates? Pediatrics 1996; 98: 1062–8PubMed
29.
go back to reference Bardenheier BH, Yusuf HR, Rosenthal J, et al. Factors associated with underim-munization at 3 months of age in four medically underserved areas. Public Health Rep 2004; 119: 479–85PubMedCrossRef Bardenheier BH, Yusuf HR, Rosenthal J, et al. Factors associated with underim-munization at 3 months of age in four medically underserved areas. Public Health Rep 2004; 119: 479–85PubMedCrossRef
30.
go back to reference Daniels D, Jiles RB, Klevens RM, et al. Undervaccinated African-American preschoolers: a case of missed opportunities. Am J Prev Med 2001; 20 (4 Suppl.): 61–8PubMedCrossRef Daniels D, Jiles RB, Klevens RM, et al. Undervaccinated African-American preschoolers: a case of missed opportunities. Am J Prev Med 2001; 20 (4 Suppl.): 61–8PubMedCrossRef
31.
go back to reference John TJ, Samuel R. Herd immunity and herd effect: new insights and definitions. Eur J Epidemiol 2000; 16: 601–6PubMedCrossRef John TJ, Samuel R. Herd immunity and herd effect: new insights and definitions. Eur J Epidemiol 2000; 16: 601–6PubMedCrossRef
32.
go back to reference Davis RM, Whitman EE, Orenstein WA, et al. A persistent outbreak of measles despite appropriate prevention and control measures. Am J Epidemiol 1987; 126: 438–49PubMed Davis RM, Whitman EE, Orenstein WA, et al. A persistent outbreak of measles despite appropriate prevention and control measures. Am J Epidemiol 1987; 126: 438–49PubMed
33.
go back to reference Gustafson TL, Lievens AW, Brunell PA, et al. Measles outbreak in a fully immunized secondary-school population. N Engl J Med 1987; 316: 771–4PubMedCrossRef Gustafson TL, Lievens AW, Brunell PA, et al. Measles outbreak in a fully immunized secondary-school population. N Engl J Med 1987; 316: 771–4PubMedCrossRef
34.
go back to reference Kuter BJ, Weibel RE, Guess HA. Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies. Vaccine 1991; 9: 643–7PubMedCrossRef Kuter BJ, Weibel RE, Guess HA. Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies. Vaccine 1991; 9: 643–7PubMedCrossRef
35.
go back to reference Weibel RE, Neff BJ, Kuter BJ. Live attenuated varicella vaccine: efficacy trial in healthy children. N Engl J Med 1984; 310: 1409–15PubMedCrossRef Weibel RE, Neff BJ, Kuter BJ. Live attenuated varicella vaccine: efficacy trial in healthy children. N Engl J Med 1984; 310: 1409–15PubMedCrossRef
36.
go back to reference Omer SB, Pan WK, Halsey NA, et al. Nonmedical exemptions to school immunization requirements: secular trends and association of state policies with pertussis incidence. JAMA 2006; 296: 1757–63PubMedCrossRef Omer SB, Pan WK, Halsey NA, et al. Nonmedical exemptions to school immunization requirements: secular trends and association of state policies with pertussis incidence. JAMA 2006; 296: 1757–63PubMedCrossRef
37.
go back to reference Hinman AR, Orenstein WA, Williamson DE, et al. Childhood immunization: laws that work. J Law Med Ethics 2002; 30 (3 Suppl.): 122–7PubMed Hinman AR, Orenstein WA, Williamson DE, et al. Childhood immunization: laws that work. J Law Med Ethics 2002; 30 (3 Suppl.): 122–7PubMed
38.
go back to reference Feikin DR, Lezotte DC, Hamman RF, et al. Individual and community risks of measles and pertussis associated with personal exemptions to immunization. JAMA 2000; 284: 3145–50PubMedCrossRef Feikin DR, Lezotte DC, Hamman RF, et al. Individual and community risks of measles and pertussis associated with personal exemptions to immunization. JAMA 2000; 284: 3145–50PubMedCrossRef
40.
go back to reference Aberle JH, Aberle SW, Pracher E, et al. Single versus dual respiratory virus infections in hospitalized infants: impact on clinical course of disease and interferon-gamma response. Pediatr Infect Dis J 2005; 24: 605–10PubMedCrossRef Aberle JH, Aberle SW, Pracher E, et al. Single versus dual respiratory virus infections in hospitalized infants: impact on clinical course of disease and interferon-gamma response. Pediatr Infect Dis J 2005; 24: 605–10PubMedCrossRef
41.
go back to reference Meyeroff A, Jacobs RJ, Greenberg DP, et al. Clinician satisfaction with vaccination visits and the role of multiple injections, results from the COVISE study. Clin Pediatr 2004; 43: 87–93CrossRef Meyeroff A, Jacobs RJ, Greenberg DP, et al. Clinician satisfaction with vaccination visits and the role of multiple injections, results from the COVISE study. Clin Pediatr 2004; 43: 87–93CrossRef
42.
go back to reference Committee on Community Health Services and Committee on Practice and Ambulatory Medicine. Increasing immunization coverage. Pediatrics 2003; 112: 993–6CrossRef Committee on Community Health Services and Committee on Practice and Ambulatory Medicine. Increasing immunization coverage. Pediatrics 2003; 112: 993–6CrossRef
43.
go back to reference Randolph GD, Murray M, Swanson JA, et al. Behind schedule: improving access to care for children one practice at a time. Pediatrics 2004; 113: 230–7CrossRef Randolph GD, Murray M, Swanson JA, et al. Behind schedule: improving access to care for children one practice at a time. Pediatrics 2004; 113: 230–7CrossRef
44.
go back to reference O’Brien L, Taddio A, Ipp M, et al. Topical 4% amethocaine gel reduces the pain of subcutaneous measles-mumps-rubella vaccination. Pediatrics 2004; 114: e720–4PubMedCrossRef O’Brien L, Taddio A, Ipp M, et al. Topical 4% amethocaine gel reduces the pain of subcutaneous measles-mumps-rubella vaccination. Pediatrics 2004; 114: e720–4PubMedCrossRef
45.
go back to reference Cohen LL, Blount RL, Cohen RJ, et al. Comparative study of distraction versus topical anesthesia for pediatric pain management during immunizations. Health Psychol 1999; 18: 591–8PubMedCrossRef Cohen LL, Blount RL, Cohen RJ, et al. Comparative study of distraction versus topical anesthesia for pediatric pain management during immunizations. Health Psychol 1999; 18: 591–8PubMedCrossRef
46.
go back to reference Koslap-Petraco MB, Parsons T. Communicating the benefits of combination vaccines to parents and health care providers. J Pediatr Health Care 2003; 17: 53–7PubMedCrossRef Koslap-Petraco MB, Parsons T. Communicating the benefits of combination vaccines to parents and health care providers. J Pediatr Health Care 2003; 17: 53–7PubMedCrossRef
47.
go back to reference Gust DA, Strine TW, Maurice E, et al. Underimmunization among children: effects of vaccine safety concerns on immunization status. Pediatrics 2004; 114: 16–22CrossRef Gust DA, Strine TW, Maurice E, et al. Underimmunization among children: effects of vaccine safety concerns on immunization status. Pediatrics 2004; 114: 16–22CrossRef
48.
go back to reference Gregson AL, Edelman R. Does antigenic overload exist? The role of multiple immunizations in infants. Immunol Allergy Clin North Am 2003; 23: 649–64PubMedCrossRef Gregson AL, Edelman R. Does antigenic overload exist? The role of multiple immunizations in infants. Immunol Allergy Clin North Am 2003; 23: 649–64PubMedCrossRef
49.
go back to reference Gangarosa EJ, Galazka AM, Wolfe CR, et al. Impact of anti-vaccine movements on pertussis control: the untold story. Lancet 1998; 351: 356–61PubMedCrossRef Gangarosa EJ, Galazka AM, Wolfe CR, et al. Impact of anti-vaccine movements on pertussis control: the untold story. Lancet 1998; 351: 356–61PubMedCrossRef
Metadata
Title
Delays in Immunization Have Potentially Serious Health Consequences
Author
Prof. Fernando A. Guerra
Publication date
01-05-2007
Publisher
Springer International Publishing
Published in
Pediatric Drugs / Issue 3/2007
Print ISSN: 1174-5878
Electronic ISSN: 1179-2019
DOI
https://doi.org/10.2165/00148581-200709030-00002

Other articles of this Issue 3/2007

Pediatric Drugs 3/2007 Go to the issue